Relevance,RGD ID,Symbol,Name,LOD,P Value,Trait,Sub Trait,Chr,Start,Stop,Species,Annotations,Match,Type 1000,2317029,Aia19,Adjuvant induced arthritis QTL 19,2.98,,joint integrity trait (VT:0010548),left rear ankle joint diameter (CMO:0002149),10,69385595,112626471,Rat,n/a,region,qtl 1000,61325,Aia5,Adjuvant induced arthritis QTL 5,,0.01,joint integrity trait (VT:0010548),joint inflammation composite score (CMO:0000919),10,24483076,107857673,Rat,n/a,region,qtl 1000,2317039,Aia6,Adjuvant induced arthritis QTL 6,4.31,,joint integrity trait (VT:0010548),right rear ankle joint diameter (CMO:0002150),10,69385595,112626471,Rat,n/a,region,qtl 1000,12880055,Am11,Aortic mass QTL 11,,0.004,aorta mass (VT:0002845),aorta weight to aorta length to body weight ratio (CMO:0002722),10,86962563,99303173,Rat,n/a,region,qtl 1000,2306970,Anxrr22,Anxiety related response QTL 22,5.95,,fear/anxiety-related behavior trait (VT:1000241),number of periods of voluntary immobility (CMO:0001045),10,64648175,101691360,Rat,n/a,region,qtl 1000,1554317,Bmd4,Bone mineral density QTL 4,9.4,0.0001,lumbar vertebra mineral mass (VT:0010511),volumetric bone mineral density (CMO:0001553),10,20170031,102897474,Rat,n/a,region,qtl 1000,2300172,Bmd57,Bone mineral density QTL 57,9.8,0.0001,femur mineral mass (VT:0010011),volumetric bone mineral density (CMO:0001553),10,73008136,112626471,Rat,n/a,region,qtl 1000,61387,Bp1,Blood pressure QTL 1,5.1,,arterial blood pressure trait (VT:2000000),diastolic blood pressure (CMO:0000005),10,53621375,112626471,Rat,n/a,region,qtl 1000,61387,Bp1,Blood pressure QTL 1,5.1,,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),10,53621375,112626471,Rat,n/a,region,qtl 1000,631555,Bp134,Blood pressure QTL 134,,0.001,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),10,83389828,94488181,Rat,n/a,region,qtl 1000,1298069,Bp168,Blood pressure QTL 168,5.5,,blood pressure trait (VT:0000183),systolic blood pressure (CMO:0000004),10,27237530,101482600,Rat,n/a,region,qtl 1000,1357344,Bp249,Blood pressure QTL 249,,0.0001,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),10,69123603,101482600,Rat,n/a,region,qtl 1000,1579919,Bp281,Blood pressure QTL 281,,0.01,arterial blood pressure trait (VT:2000000),mean arterial blood pressure (CMO:0000009),10,77055741,98282519,Rat,n/a,region,qtl 1000,1642980,Bp300,Blood pressure QTL 300,,,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),10,70800069,112626471,Rat,n/a,region,qtl 1000,2292438,Bp311,Blood pressure QTL 311,,,arterial blood pressure trait (VT:2000000),mean arterial blood pressure (CMO:0000009),10,78970279,112626471,Rat,n/a,region,qtl 1000,2313856,Bp342,Blood pressure QTL 342,4.4,0.0001,life span trait (VT:0005372),age at time of death (CMO:0001193),10,90296897,99492409,Rat,n/a,region,qtl 1000,10450495,Bp383,Blood pressure QTL 383,,0.002,arterial blood pressure trait (VT:2000000),mean arterial blood pressure (CMO:0000009),10,78970279,98282519,Rat,n/a,region,qtl 1000,10450498,Bp384,Blood pressure QTL 384,,0.002,arterial blood pressure trait (VT:2000000),mean arterial blood pressure (CMO:0000009),10,70166960,112626471,Rat,n/a,region,qtl 1000,70364,Bp72,Blood pressure QTL 72,,,arterial blood pressure trait (VT:2000000),mean arterial blood pressure (CMO:0000009),10,91548145,99492409,Rat,n/a,region,qtl 1000,631542,Bp82,Blood pressure QTL 82,6.8,,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),10,27237530,102427718,Rat,n/a,region,qtl 1000,631547,Bp87,Blood pressure QTL 87,4.5,,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),10,50638337,95638337,Rat,n/a,region,qtl 1000,61396,Bp9,Blood pressure QTL 9,4.8,0.0001,arterial blood pressure trait (VT:2000000),systolic blood pressure (CMO:0000004),10,71692298,112626471,Rat,n/a,region,qtl 1000,2293646,Bss25,Bone structure and strength QTL 25,10.96,0.0001,femur morphology trait (VT:0000559),femur cross-sectional area (CMO:0001661),10,73008136,112626471,Rat,n/a,region,qtl 1000,2293663,Bss33,Bone structure and strength QTL 33,9.34,0.0001,femur strength trait (VT:0010010),femur midshaft polar moment of inertia (CMO:0001669),10,73008136,112626471,Rat,n/a,region,qtl 1000,2293698,Bss43,Bone structure and strength QTL 43,5.33,0.0001,lumbar vertebra size trait (VT:0010518),lumbar vertebra cross-sectional area (CMO:0001689),10,62096293,107096293,Rat,n/a,region,qtl 1000,1549831,Bss6,Bone structure and strength QTL 6,4,,lumbar vertebra strength trait (VT:0010574),vertebra ultimate force (CMO:0001678),10,60450007,105450007,Rat,n/a,region,qtl 1000,2313105,Bss79,Bone structure and strength QTL 79,1.8,0.0001,tibia size trait (VT:0100001),tibia midshaft cross-sectional area (CMO:0001717),10,65992275,110992275,Rat,n/a,region,qtl 1000,2313103,Bss80,Bone structure and strength QTL 80,2,0.0001,tibia strength trait (VT:1000284),tibia midshaft endosteal cross-sectional area (CMO:0001716),10,65992275,110992275,Rat,n/a,region,qtl 1000,4889948,Bss91,Bone structure and strength QTL 91,4,,tibia area (VT:1000281),tibia midshaft total cross-sectional area (CMO:0001715),10,85513822,95638337,Rat,n/a,region,qtl 1000,6893357,Bw102,Body weight QTL 102,0.5,0.36,body mass (VT:0001259),body weight (CMO:0000012),10,83389828,104994768,Rat,n/a,region,qtl 1000,6893366,Bw106,Body weight QTL 106,0.3,0.47,body mass (VT:0001259),body weight (CMO:0000012),10,73467158,112626471,Rat,n/a,region,qtl 1000,7387312,Bw125,Body weight QTL 125,3,0.0047,retroperitoneal fat pad mass (VT:0010430),retroperitoneal fat pad weight (CMO:0000356),10,67880046,112626471,Rat,n/a,region,qtl 1000,70164,Bw21,Body weight QTL 21,4.36,0.00005,body mass (VT:0001259),body weight (CMO:0000012),10,55679084,102427604,Rat,n/a,region,qtl 1000,2303589,Bw87,Body weight QTL 87,2,,body mass (VT:0001259),body weight (CMO:0000012),10,85079943,112626471,Rat,n/a,region,qtl 1000,70171,Cari1,Carrageenan-induced inflammation QTL 1,4.9,0.0005,hypodermis integrity trait (VT:0010550),inflammatory exudate volume (CMO:0001429),10,55678976,112626471,Rat,n/a,region,qtl 1000,61427,Cia16,Collagen induced arthritis QTL 16,3.2,,joint integrity trait (VT:0010548),joint inflammation composite score (CMO:0000919),10,6429075,99492409,Rat,n/a,region,qtl 1000,631267,Cia20,Collagen induced arthritis QTL 20,3.2,,joint integrity trait (VT:0010548),joint inflammation composite score (CMO:0000919),10,24483076,107857673,Rat,n/a,region,qtl 1000,631268,Cia21,Collagen induced arthritis QTL 21,3.1,,joint integrity trait (VT:0010548),joint inflammation composite score (CMO:0000919),10,14827894,107857673,Rat,n/a,region,qtl 1000,631269,Cia22,Collagen induced arthritis QTL 22,8.9,,joint integrity trait (VT:0010548),joint inflammation composite score (CMO:0000919),10,41260363,107857673,Rat,n/a,region,qtl 1000,631270,Cia23,Collagen induced arthritis QTL 23,3.9,,joint integrity trait (VT:0010548),joint inflammation composite score (CMO:0000919),10,41260363,107857673,Rat,n/a,region,qtl 1000,1302404,Cia27,Collagen induced arthritis QTL 27,2.6,0.0045,joint integrity trait (VT:0010548),experimental arthritis severity measurement (CMO:0001459),10,79927661,112626471,Rat,n/a,region,qtl 1000,61449,Ciaa2,CIA Autoantibody QTL 2,7.1,,blood autoantibody amount (VT:0003725),calculated serum anti-type 2 collagen antibody titer (CMO:0001279),10,65590122,110590122,Rat,n/a,region,qtl 1000,1331791,Cm31,Cardiac mass QTL 31,3.84606,,heart mass (VT:0007028),heart wet weight (CMO:0000069),10,23861015,112626471,Rat,n/a,region,qtl 1000,1354608,Cm33,Cardiac mass QTL 33,2.8,,heart left ventricle mass (VT:0007031),heart left ventricle wet weight (CMO:0000071),10,56698730,101698730,Rat,n/a,region,qtl 1000,1558643,Cm44,Cardiac mass QTL 44,4.8,0.0000368,heart mass (VT:0007028),heart wet weight (CMO:0000069),10,64648175,102149713,Rat,n/a,region,qtl 1000,631535,Cm51,Cardiac mass QTL 51,3,,heart mass (VT:0007028),calculated heart weight (CMO:0000073),10,53637485,94807701,Rat,n/a,region,qtl 1000,6893336,Cm75,Cardiac mass QTL 75,0.1,0.87,heart mass (VT:0007028),heart weight to body weight ratio (CMO:0000074),10,64648175,102149713,Rat,n/a,region,qtl 1000,1581559,Eae18,Experimental allergic encephalomyelitis QTL 18,,0.00002,nervous system integrity trait (VT:0010566),experimental autoimmune encephalomyelitis severity score (CMO:0001419),10,67988218,110992091,Rat,n/a,region,qtl 1000,2306792,Ean4,Experimental allergic neuritis QTL 4,4,,nervous system integrity trait (VT:0010566),splenic interferon gamma-secreting mononuclear cell count (CMO:0002122),10,86977861,97308569,Rat,n/a,region,qtl 1000,2306793,Ean5,Experimental allergic neuritis QTL 5,4.7,,nervous system integrity trait (VT:0010566),splenic interferon gamma-secreting mononuclear cell count (CMO:0002122),10,75045391,97308358,Rat,n/a,region,qtl 1000,2292617,Ept18,Estrogen-induced pituitary tumorigenesis QTL 18,3.9,,pituitary gland mass (VT:0010496),pituitary gland wet weight (CMO:0000853),10,75983805,99492217,Rat,n/a,region,qtl 1000,1358188,Ept9,Estrogen-induced pituitary tumorigenesis QTL 9,3.9,,pituitary gland mass (VT:0010496),pituitary gland wet weight (CMO:0000853),10,75983805,99492217,Rat,n/a,region,qtl 1000,2317754,Glom25,Glomerulus QTL 25,3.5,,urine protein amount (VT:0005160),urine protein level (CMO:0000591),10,86566908,112626471,Rat,n/a,region,qtl 1000,2316949,Gluco60,Glucose level QTL 60,3.7,,blood glucose amount (VT:0000188),blood glucose level (CMO:0000046),10,14827894,110992275,Rat,n/a,region,qtl 1000,2300218,Hpcl2,Hepatic cholesterol level QTL 2,,,liver cholesterol amount (VT:0010498),liver cholesterol level (CMO:0001597),10,46593021,98939209,Rat,n/a,region,qtl 1000,1359017,Hrtrt21,Heart rate QTL 21,2.4,,heart pumping trait (VT:2000009),heart rate (CMO:0000002),10,55224855,100224855,Rat,n/a,region,qtl 1000,2312672,Insul15,Insulin level QTL 15,,0.01,blood insulin amount (VT:0001560),serum insulin level (CMO:0000358),10,60875260,105875260,Rat,n/a,region,qtl 1000,2301398,Kidm38,Kidney mass QTL 38,,0.002,kidney mass (VT:0002707),both kidneys wet weight to body weight ratio (CMO:0000340),10,86962563,99303173,Rat,n/a,region,qtl 1000,2303118,Mamtr7,Mammary tumor resistance QTL 7,,0.003,mammary gland integrity trait (VT:0010552),mammary tumor growth rate (CMO:0000344),10,9841807,108540162,Rat,n/a,region,qtl 1000,1600367,Mcs15,Mammary carcinoma susceptibility QTL 15,4.5,,mammary gland integrity trait (VT:0010552),mammary tumor number (CMO:0000343),10,88544136,107545372,Rat,n/a,region,qtl 1000,70193,Mcs7,Mammary carcinoma susceptibility QTL 7,2.38,,mammary gland integrity trait (VT:0010552),mammary tumor number (CMO:0000343),10,75544754,112626471,Rat,n/a,region,qtl 1000,2298548,Neuinf7,Neuroinflammation QTL 7,3.4,,nervous system integrity trait (VT:0010566),spinal cord RT1-B protein level (CMO:0002132),10,75544754,112626471,Rat,n/a,region,qtl 1000,634320,Niddm49,Non-insulin dependent diabetes mellitus QTL 49,4.41,,blood glucose amount (VT:0000188),plasma glucose level (CMO:0000042),10,91689348,112626471,Rat,n/a,region,qtl 1000,61363,Oia3,Oil induced arthritis QTL 3,,0.001,joint integrity trait (VT:0010548),joint inflammation composite score (CMO:0000919),10,90296897,112626471,Rat,n/a,region,qtl 1000,631538,Oia5,Oil induced arthritis QTL 5,,,joint integrity trait (VT:0010548),joint inflammation composite score (CMO:0000919),10,90041957,112626471,Rat,n/a,region,qtl 1000,4889492,Pancm2,Pancreatic morphology QTL 2,3.2,,pancreatic beta cell morphology trait (VT:0005217),ratio of insulin-positive cell area to total area of splenic region of pancreas (CMO:0001814),10,80239190,112626471,Rat,n/a,region,qtl 1000,61354,Pia10,Pristane induced arthritis QTL 10,,0.01,joint integrity trait (VT:0010548),joint inflammation composite score (CMO:0000919),10,24483076,107857673,Rat,n/a,region,qtl 1000,724556,Pur2,Proteinuria QTL 2,5.5,,urine protein amount (VT:0005160),urine protein level (CMO:0000591),10,22901497,93886300,Rat,n/a,region,qtl 1000,1300107,Rf18,Renal function QTL 18,3.41,,urine output (VT:0003620),timed urine volume (CMO:0000260),10,81515116,101758478,Rat,n/a,region,qtl 1000,1576308,Schws1,Schwannoma susceptibility QTL 1,,0.0041,nervous system integrity trait (VT:0010566),percentage of study population developing trigeminal nerve neurilemmomas during a period of time (CMO:0002017),10,41260363,106105607,Rat,n/a,region,qtl 1000,1549846,Scl47,Serum cholesterol level QTL 47,3.6,,blood cholesterol amount (VT:0000180),serum total cholesterol level (CMO:0000363),10,53104718,98104718,Rat,n/a,region,qtl 1000,2312668,Scl65,Serum cholesterol level QTL 65,,0.001,blood cholesterol amount (VT:0000180),serum total cholesterol level (CMO:0000363),10,60875260,105875260,Rat,n/a,region,qtl 1000,2312662,Slep8,Serum leptin concentration QTL 8,,0.05,blood leptin amount (VT:0005667),serum leptin level (CMO:0000780),10,60875260,105875260,Rat,n/a,region,qtl 1000,1298078,Stresp5,Stress response QTL 5,2.99,0.00025,blood corticosterone amount (VT:0005345),plasma corticosterone level (CMO:0001173),10,43289657,108540162,Rat,n/a,region,qtl 1000,631530,Tls3,T-lymphoma susceptibility QTL 3,0,0.0001,thymus integrity trait (VT:0010555),percentage of study population developing T-cell lymphomas during a period of time (CMO:0001911),10,53625815,98939209,Rat,n/a,region,qtl 1000,631552,Vetf2,Vascular elastic tissue fragility QTL 2,4.5,0.0002,aorta elastic tissue integrity trait (VT:0010556),artery internal elastic lamina non-tumorous lesion count (CMO:0001913),10,36185929,95845311,Rat,n/a,region,qtl